4 diabetes tech execs on the future of multi-analyte glucose sensors

4 diabetes tech execs on the future of multi-analyte glucose sensors is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-06-22

Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.

Source: MedTech Dive